Dopamine receptor-mediated regulation of striatal cholinergic activity: Positron emission tomography studies with norchloro [18F] fluoroepibatidine

Journal of Neurochemistry

Volumn 74, Issue 4, 2000, Pages 1514-1521

  Ding, Yu Shin ^a   Logan, Jean ^a   Bermel, Rob ^a   Garza, Victor ^a   Rice, Onarae ^a   Fowler, Joanna S ^a   Volkow, Nora D ^a,b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Dopamine D1 receptor; Dopamine D2 receptor; Epibatidine; Fluorine 18; Nicotinic acetylcholine receptors; Positron emission tomography

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; EPIBATIDINE; NICOTINIC RECEPTOR; NORCHLOROFLUOROEPIBATIDINE; QUINPIROLE; RACLOPRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BABOON; CEREBELLUM; CHOLINERGIC ACTIVITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; NEURORADIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ACETYLCHOLINE; ANIMALS; BENZAMIDES; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; CHOLINESTERASE INHIBITORS; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FEMALE; FLUORINE RADIOISOTOPES; PAPIO; PHYSOSTIGMINE; PYRIDINES; RACLOPRIDE; RADIOLIGAND ASSAY; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TOMOGRAPHY, EMISSION-COMPUTED;

ANIMALIA; PAPIO HAMADRYAS;

EID: 0034066935     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0741514.x     Document Type: Article

References (58)

1. Acquas E. and Fibiger H. C. (1998) Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition. J. Neurochem. 70, 1088-1093.
2. 1 receptors regulate striatal acetylcholine release in vivo. J. Pharmacol. Exp. Ther. 281, 360-368.
3. 2 dopamine receptors in rat striatum under freely moving conditions. Brain Res. 518, 193-198.
4. 2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J. Neurochem. 54, 2145-2148.
5. 1 receptors localized in the striatum. J. Neurochem. 59, 1555-1557.
6. Damsma G., de Boer P., Westerink B. H. C., and Fibiger H. C. (1990) Dopaminergic regulation of striatal cholinergic interneurons: an in vivo microdialysis study. Naunyn Schmiedebergs Arch. Pharmacol. 342, 523-527.
7. 1 and N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 259, 1064-1072.
8. 2 dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 277, 775-783.
9. de Boer P., Damsma G., Schram Q., Stoof J. C., Zaagsma J., and Westerink B. H. C. (1992) The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn Schmiedebergs Arch. Pharmacol. 345, 144-152.
10. 2 receptors. Eur. J. Pharmacol. 317, 257-262.
11. Dewey S. L., Brodie J. D., Fowler J. S., MacGregor R. R., Schlyer D. J., King P. T., Alexoff D. L., Volkow N. D., Shiue C.-Y., Wolf A. P., and Bendriem B. (1990a) Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain. Synapse 6, 321-327.
12. 11C-methyl]benztropine. Synapse 5, 213-223.
13. 18F]-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Synapse 7, 324-327.
14. Dewey S. L., Smith G. S., Logan J., Brodie J. D., Simkowitz P., MacGregor R. R., Fowler J. S., Volkow N. D., and Wolf A. P. (1993) Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc. Natl. Acad. Sci. USA 90, 11816-11820.
15. 18F labeled biomolecules for PET studies in the neuroscience. J. Fluorine Chem. (in press).
16. Ding Y.-S., Fowler J. S., Volkow N. D., Logan J., Gatley S. J., and Sugano Y. (1995) Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain. J. Nucl. Med. 36, 2298-2305.
17. Ding Y.-S., Gatley S. J., Fowler J. S., Volkow N. D., Aggarwal D., Logan J., Dewey S. L., Liang F., Carroll F. I., and Kuhar M. J. (1996) Mapping nicotinic acetylcholine receptors with PET. Synapse 24, 403-407.
18. 18F]norchlorofluoroepibatidine with autoradiography and a phosphor-imaging device. J. Labelled Cpd. Radiopharm. 40, 157.
19. 18F]norchlorofluoroepibatidine and its N-methyl derivative: new PET ligands for mapping nicotinic acetylcholine receptors. J. Labelled Cpd. Radiopharm. 34, 827-832.
20. 18F]fluoroepibatidine. (Abstr.) J. Nucl. Med. 39, 12p.
21. 18F]N-methyl-NFEP: kinetics, nicotine effect and toxicity. Nucl. Med. Biol. 26, 139-148.
22. Ding Y.-S., Volkow N. D., Logan J., Garza V., Pappas N., King P., and Fowler J. S. (2000) Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette. Synapse 35, 234-237.
23. 2 receptor-mediated inhibition of acetylcholine release in rabbit striatum. Naunyn Schmiedebergs Arch. Pharmacol. 345, 16-20.
24. Endres C. J. and Carson R. E. (1998) Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands. J. Cereb. Blood Flow Metab. 18, 1196-1210.
25. Gatley S. J., Andrew N. G., Logan J., Volkow N. D., and Fowler J. S. (1998) Receptor measurements using PET and SPECT, in Receptor Localization: Laboratory Methods and Procedures (Ariano E. M., eds), pp. 220-239. John Wiley and Sons, New York.
26. Gifford A. N., Bruneus M., Gatley S. J., Lan R., Makriyannis A., and Volkow N. D. (1999) Large receptor reserve for cannabinoid actions in the central nervous system. J. Pharmacol. Exp. Ther. 288, 478-483.
27. Gorell J. M. and Czarnecki B. (1986) Pharmacological evidence for direct dopaminergic regulation of striatal acetylcholine release. Life Sci. 38, 2239-2246.
28. 2 dopaminergic mechanisms affecting striatal acetylcholine release. Life Sci. 38, 2247-2254.
29. 1 and DARPP-32 gene expression in the rat striatum: an in situ hybridization study. Mol. Brain Res. 12, 131-139.
30. Imperato A., Obinu M. C., Casu M. A., Mascia M. S., Dazzi L., and Gessa G. L. (1993) Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. J. Pharmacol. Exp. Ther. 266, 557-562.
31. 2/acetylcholine interactions: PET studies of the vesamicol receptor. Neuroreport 4, 1311-1314.
32. Johnson B. J. and Bruno J. P. (1993) Striatal dopamine-acetylcholine interactions do not mediate sparing from sensorimotor deficits in rats depleted of dopamine as neonates. Soc. Neurosci. Abstr. 19, 1831.
33. 2 receptors in cholinergic neurons in the core and shell of the rat nucleus accumbens. Mol. Brain Res. 28, 169-174.
34. 2 dopamine receptor imaging agent. J. Nucl. Med. 30, 88-92.
35. Laruelle M., AbiDargham A., vanDyck C., Rosenblat W., Zea-Ponce Y., Zoghbi S. S., Baldwin R. M., Charney D., Hoffer P. B., Kung H. F., and Innis R. B. (1995) SPECT imaging of striatal dopamine release after amphetamine challenge. J. Nucl. Med. 36, 1182-1190.
36. Lehmann J. and Langer S. Z. (1983) The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience 10, 1105-1120.
37. Liu J. K. and Kato T. (1994) Effect of physostigmine on relative acetylcholine output induced by systemic treatment with scopolamine in in vivo microdialysis of rat frontal cortex. Neurochem. Int. 24, 589-596.
38. 11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 10, 740-747.
39. 1 DA receptor-mediated control of striatal acetylcholine release in vitro. Brain Res. 681, 209-212.
40. Martin-Iverson M. T. and Burger L. Y. (1995) Behavioral sensitization and tolerance to cocaine and the occupation of dopamine receptors by dopamine. Mol. Neurobiol. 11, 31-46.
41. McGeer P. L. and McGeer E. G. (1984) Cholinergic systems and cholinergic pathology, in Handbook of Neurochemistry (Lajtha A., ed), pp. 379-410. Plenum Press, New York.
42. Meltzer H. Y. and Stahl S. M. (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr. Bull. 2, 19-76.
43. Molina P. E., Ding Y.-S., Carroll F. I., Liang F., Volkow N. D., Pappas N., Kuhar M., Abumrad N., Gatley S. J., and Fowler J. S. (1997) Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity. Nucl. Med. Biol. 24, 743-747.
44. Nowak G., Arnt J., and Hyttel J. (1988) EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors. Eur. J. Pharmacol 153, 309-331.
45. Ross S. B. (1991) Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J. Neurochem. 56, 22-29.
46. 1, dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci. 31, 2883-2890.
47. 3 receptors in vivo. Eur. J. Pharmacol. 218, 373-375.
48. 3 receptors in the rat brain: a quantitative autoradiographic study. Histochem. J. 28, 791-799.
49. 3H]acetylcholine on catecholamine and serotonin axons in brain. J. Neurochem. 42, 1495-1498.
50. Spokes E. G. (1980) Neurochemical alterations in Huntington's chorea. A study of postmortem brain tissue. Brain 103, 179-210.
51. +-stimulated release of acetylcholine from rat neostriatum. Brain Res. 250, 263-270.
52. Stoof J. C., Drukarch B., de Boer P., Westerink B. H. C., and Groeneweoen H. J. (1992) Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience 47, 755-770.
53. 3H]acetylcholine release in rat striatal slices. Eur. J. Pharmacol. 211, 169-176.
54. Trabucchi M., Cheney D. L., Hanin I., and Costa E. (1975) Application of principles of steady-state kinetics to the estimation of brain acetylcholine turnover rate: effects of oxotremorine and physostigmine. J. Pharmacol. Exp. Ther. 194, 57-64.
55. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health (1994) Preparation and Maintenance of Higher Mammals During Neuroscience Experiments [NIH publication 94-3207]. U.S. Government Printing Office. Washington, D.C.
56. Vickroy T. W., Malphurs W. L., and Defiebre N. C. (1993) Absence of receptor reserve at hippocampal muscarinic autoreceptors which inhibit stimulus-dependent ACh release. J. Pharmacol. Exp. Ther. 267, 1198-1204.
57. Volkow N. D., Fowler J. S., Wang G.-J., Dewey S. L., Schlyer D., MacGregor R., Logan J., Alexoff D., Shea C., Hitzemann R., Angrist B., and Wolf A. P. (1993) Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J. Nucl. Med. 34, 609-613.
58. Wonnacott S., Soliakov L., Wilkie G., Redfern P., and Marshall D. (1996) Presynaptic nicotinic acetylcholine receptors in the brain. Drug Dev. Res. 38, 149-159.